Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Ismail Syed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucose Intolerance, Palmitic Acid, Fatty Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, JPB Foundation, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
There is a growing need for early biomarkers for Type 2 diabetes (T2D). Fatty-Acid-Hydroxy-Fatty-Acids (FAHFAs) are bioactive lipids with >580 regioisomers in human tissues. FAHFAs such as Palmitic Acid Hydroxy Stearic Acids (PAHSAs) are anti-diabetic and anti-inflammatory. PAHSA concentrations in human serum and adipose tissue strongly correlate with insulin sensitivity. Since PAHSAs and palmitic acid hydroxy oleic acids (PAHOAs) are among the most abundant FAHFAs in human serum, we investigated whether they predict worsening glucose tolerance in first-degree relatives of people with T2D. All participants had normal glucose tolerance (NGT) at baseline; 27 remained NGT (NGT-NGT) and 21 developed impaired glucose tolerance (NGT-IGT). In NGT-NGT, total PAHSA and PAHSA regioisomer concentrations were unchanged from baseline to follow-up, while in NGT-IGT participants, most PAHSA regioisomers decreased. The initial total PAHSAs, 5-PAHSA, and 9-PAHSA, and changes in these correlated inversely with worsening glucose tolerance. Low total PAHSA concentrations at baseline and the decrease in total PAHSAs, 5-PAHSAs, and 9-PAHSAs over time predicted IGT independent of initial BMI or %body fat, change in BMI or in %body fat, initial fasting glucose, fasting insulin, or triglyceride/HDL ratio. In contrast, baseline and follow-up total PAHOA and PAHOA regioisomer levels were higher in NGT-IGT than NGT-NGT, and some PAHOA regioisomers increased during follow-up in NGT-IGT. Higher initial total PAHOAs predicted IGT independent of the same clinical variables. Thus, lower serum PAHSAs and higher PAHOAs predict worsening glucose tolerance/IGT independent of BMI, %body fat, or change in these parameters, even in lean, relatively young people.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. Electronic address: isyed@bidmc.harvard.edu.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
- The Lundberg Laboratory for Diabetes Research, Departments of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. Electronic address: bkahn@bidmc.harvard.edu.
Förderung
- NIDDK NIH HHS
- JPB Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Syed, I., Sluis, K., Aryal, P., Solomon, Z., Patel, R., Konduri, S., Siegel, D., Smith, U., & Kahn, B. B. (2025). Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100819
Vancouver
Syed I, Sluis K, Aryal P, Solomon Z, Patel R, Konduri S, et al. Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100819
BibTeX
@article{Syed2025,
author = {Syed, Ismail and Sluis, Ken and Aryal, Pratik and Solomon, Zachary and Patel, Rucha and Konduri, Srihari and Siegel, Dionicio and Smith, Ulf and Kahn, Barbara B},
title = {Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100819}
}
EUVIMED